Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C61694
http://purl.obolibrary.org/obo/NCIT_C61694
|
|---|---|
| Preferred Name | Cyclophosphamide Anhydrous |
| Definitions |
The anhydrous form of cyclophosphamide, a synthetic nitrogen mustard alkylating agent, with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to active metabolites including phosphoramide mustard, which binds to and crosslinks DNA and RNA, thereby inhibiting DNA replication and protein synthesis. This agent, at low doses, is also a potent immunosuppressant primarily by depleting T-regulatory cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The anhydrous form of cyclophosphamide, a synthetic nitrogen mustard alkylating agent, with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to active metabolites including phosphoramide mustard, which binds to and crosslinks DNA and RNA, thereby inhibiting DNA replication and protein synthesis. This agent, at low doses, is also a potent immunosuppressant primarily by depleting T-regulatory cells. |
|---|---|
| prefLabel | Cyclophosphamide Anhydrous
|
| label | Cyclophosphamide Anhydrous
|
| CHEBI_ID | CHEBI:4027
|
| code | C61694
|
| prefixIRI | NCIT:C61694
|
| in_subset | |
| Preferred_Name | Cyclophosphamide Anhydrous
|
| FDA_UNII_Code | 6UXW23996M
|
| Contributing_Source | FDA
|
| Chemical_Formula | C7H15Cl2N2O2P
|
| Maps_To | Cyclophosphamide Anhydrous
|
| CAS_Registry | 50-18-0
|
| Legacy Concept Name | Cyclophosphamide_Anhydrous
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C1880207
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |